RESEARCH PAPER
Health system challenges affecting the implementation of isoniazid preventive therapy in people living with HIV in Lesotho
 
More details
Hide details
 
Submission date: 2018-01-12
 
 
Final revision date: 2018-04-26
 
 
Acceptance date: 2018-04-30
 
 
Publication date: 2018-11-20
 
 
HIV & AIDS Review 2018;17(4):299-307
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The six-month course of isoniazid preventive therapy (IPT) has been demonstrated to have significant benefits in mitigating the occurrence of tuberculosis (TB), particularly in high TB burden settings. However, its implementation in Sub-Saharan countries remains subdued for obscure reasons. This study investigated the factors inhibiting IPT uptake in the sub-Saharan country of Lesotho, which has one of the highest rates of TB incidences globally.

Material and methods:
Data were obtained from 46 healthcare workers, key informants at the Ministry of Health of Lesotho, and representatives of partner organizations, who were purposively selected for their roles in IPT implementation. Data were coded to identify themes, and the emerging themes were benchmarked to previous typologies for evaluating the implementation of best practices in health interventions, namely effectiveness, reach, sustainability, and adaptation. Each major theme was further linked to the World Health Organization’s ‘six building blocks of a health system’.

Results:
Challenges affecting the implementation of IPT were as follows: ineffective TB screening due to challenged decentralization of human immunodeficiency virus (HIV)/TB services, late detection of side effects linked to weak monitoring systems, and inefficient health information systems. Further challenges in the health system included interrupted supply chains due to insufficient health system financing, while inadequate healthcare workers’ education on IPT implementation was also noted.

Conclusions:
These findings indicate that a wide spectrum of challenges has affected the implementation of IPT in Lesotho, and this indicates the need for ‘health systems approach’ to the implementation of IPT in Lesotho and other countries with similar challenges.

REFERENCES (29)
1.
WHO. Global tuberculosis report 2014. World Health Organization, Geneva 2014.
 
2.
Yamey G. What are the barriers to scaling up health interventions in low and middle income countries? A qualitative study of academic leaders in implementation science. Global Health 2012; 8: 11.
 
3.
WHO. Interim policy on collaborative TB/HIV activities. WHO Press, Geneva 2004.
 
4.
Adams LV, Talbot EA, Odato K, et al. Interventions to improve delivery of isoniazid preventive therapy: an overview of systematic reviews. BMC Infect Dis 2014; 14: 281.
 
5.
Adjobimey M, Masserey E, Adjonou C, et al. Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin. Int J Tuberc Lung Dis 2016; 20: 1055-1059.
 
6.
Ayele HT, van Mourik MS, Bonten MJ. Predictors of adherence to isoniazid preventive therapy in HIV patients in Ethiopia: A prospective cohort study. Int J Infect Dis 2016; 45 (Suppl 1): 386.
 
7.
Charles MK, Lindegren ML, Wester CW, et al.; International epidemiology Databases to Evaluate AIDS (IeDEA) Collaboration. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (“Three I’s”) and HIV-Tuberculosis Service Integration in Lower Income Countries. PLoS One 2016; 11: e0153243.
 
8.
Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2004; 2: CD000363.
 
9.
McCannon CJ, Berwick DM, Massoud MR. The science of large-scale change in global health. JAMA 2007; 298: 1937-1939.
 
10.
Buekens P, Keusch G, Belizan J, et al. Evidence-based global health. JAMA 2004; 291: 2639-2641.
 
11.
WHO. Strengthening health systems to improve health outcomes: WHO’s framework for action. WHO Press, Geneva 2007.
 
12.
Spencer LM, Schooley MW, Anderson LA, et al. Seeking Best Practices: A Conceptual Framework for Planning and Improving Evidence-Based Practices. Prev Chronic Dis 2013; 10: 130186.
 
13.
Getahun H, Granich R, Sculier D, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS 2010; 24: S57-65.
 
14.
GoL. National TB and Leprosy Control Strategic Plan 2013-2017. Government of Lesotho, Maseru 2013.
 
15.
United Nations. Assessing progress in Africa toward the Millennium Development Goals. United Nations, New York 2010.
 
16.
PEPFAR Lesotho. Lesotho Country Operational Plan (COP) 2016 Strategic Direction Summary 2016 [Online]. Available at: https://www.pepfar.gov/documen... (Accessed: 7 March 2017).
 
17.
Tesfaye A, Fiseha D, Assefa D, et al. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia. BMC Infect Dis 2017; 17: 318.
 
18.
Mugomeri E, Musa NK, Chatanga P. Haemoglobin response to routine iron and folate supplementation during pregnancy in an HIV-endemic rural area of Roma, Lesotho. Medical Technology SA 2016; 30: 10-14.
 
19.
Tiam A, Machekano R, Gounder CR, et al. Preventing tuberculosis among HIV-infected pregnant women in lesotho: the case for rolling out active case finding and isoniazid preventive therapy. J Acquir Immune Defic Syndr 2014; 67: e5-e11.
 
20.
Bemelmans M, Goux D, Baert S, et al. The uncertain future of lay counsellors: continuation of HIV services in Lesotho under pressure. Health Policy Plan 2016; 31: 592-599.
 
21.
Ayele HT, van Mourik MS, Bonten MJ. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study. BMC Infect Dis 2015; 15: 334.
 
22.
WHO. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. WHO Press, Geneva 2011.
 
23.
Buchbinder SB, Shanks NH. Introduction to health care management. Jones & Bartlett Publishers, 2016.
 
24.
Noé A, Ribeiro RM, Anselmo R, et al. Knowledge, attitudes and practices regarding tuberculosis care among health workers in Southern Mozambique. BMC Pulm Med 2017; 17: 2.
 
25.
Collins S, Juste J, Koenig S, et al. CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001. Int J Tuberc Lung Dis 2015; 19: 50-57.
 
26.
Churchyard G, Mametja L, Mvusi L, et al. Tuberculosis control in South Africa: Successes, challenges and recommendations. S Afr Med J 2014; 104 (3 Suppl 1): 244-248.
 
27.
Saito S, Howard AA, Chege D, et al. Monitoring quality at scale: implementing quality assurance in a diverse, multicountry HIV program. AIDS 2015; 29 Suppl 2: S129-136.
 
28.
WHO. Global tuberculosis report 2015. WHO/HTM/TB/2015.22. WHO Press, Geneva 2015.
 
29.
Temprano ANRS 12136 Study Group; Danel C, Moh R, Gabillard D, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med 2015; 373: 808-822.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top